Breaking News Instant updates and real-time market news.

CZR

Caesars

$11.30

0.4 (3.67%)

, PENN

Penn National

$27.02

0.82 (3.13%)

08:29
04/13/18
04/13
08:29
04/13/18
08:29

Jefferies sees opportunity in smid-cap casino stocks after selloff

The recent selloff in smid-cap casino stocks has been driven by the impact of severe weather in the regional markets as well as a challenging quarter in Las Vegas, Jefferies analyst David Katz tells investors in a research note. Following the release of positive March gross gaming revenue from several important regional markets, the context for the quarter is more positive, Katz adds. He believes the share selloff is overdone and presents opportunities in Caesars (CZR) and Penn National Gaming (PENN), among others.

CZR

Caesars

$11.30

0.4 (3.67%)

PENN

Penn National

$27.02

0.82 (3.13%)

GDEN

Golden Entertainment

$23.72

0.3 (1.28%)

ERI

Eldorado Resorts

$35.50

0.9 (2.60%)

CHDN

Churchill Downs

$235.95

-0.85 (-0.36%)

GLPI

Gaming and Leisure Properties

$33.36

-0.44 (-1.30%)

  • 25

    Apr

  • 26

    Apr

CZR Caesars
$11.30

0.4 (3.67%)

03/07/18
NOMU
03/07/18
UPGRADE
NOMU
Buy
Caesars upgraded to Buy from Neutral at Nomura Instinet
01/18/18
JEFF
01/18/18
INITIATION
Target $14
JEFF
Hold
Caesars initiated with a Hold at Jefferies
Jefferies analyst David Katz initiated coverage of the casino industry, starting Caesars with a Hold rating and $14 price target.
10/24/17
SUSQ
10/24/17
NO CHANGE
SUSQ
Caesars has path to $21 per share, says Susquehanna
Susquehanna analyst Joseph Stauff contends that Caesar's has emerged from bankruptcy as a "very compelling" long idea, citing its potential to drive better than expected EBITDA growth. He identifies $600M of incremental EBITDA that can be added by its Las Vegas renovations, licensing agreements and margin improvement, which if added to current estimates would assume a $21 per share stock, he tells investors.
04/05/18
NOMU
04/05/18
NO CHANGE
Target $15
NOMU
Buy
Nomura sees 'several' positive catalysts to reverse Caesars sentiment
Nomura Instinet analyst Harry Curtis sees "several" positive catalysts that could reverse the negative sentiment on shares of Caesars. These include Q2 RevPAR strength in Las Vegas, which is being underappreciated by investors, Curtis tells investors in a research note. He notes the stock has 36% upside potential to his $15 price target along with a 13% free cash flow yield on 2019 estimates. Curtis keeps a Buy rating on Caesars.
PENN Penn National
$27.02

0.82 (3.13%)

01/18/18
JEFF
01/18/18
INITIATION
Target $39
JEFF
Buy
Penn National initiated with a Buy at Jefferies
Jefferies analyst David Katz initiated Penn National with a Buy and $39 price target.
01/18/18
JEFF
01/18/18
INITIATION
Target $43
JEFF
Buy
MGM Resorts initiated with a Buy at Jefferies
Jefferies analyst David Katz started MGM Resorts (MGM) with a Buy rating and $43 price target. The analyst says the Cotai opening in the near term and positive capital deployment trump concerns over challenging Las Vegas comparisons. Katz initiated 11 Gaming names after today's close, naming Wynn Resorts (WYNN), Eldorado Resorts (ERI) and Penn National (PENN) his top picks.
01/22/18
DBAB
01/22/18
NO CHANGE
Target $38
DBAB
Buy
Penn National price target raised to $38 from $32 at Deutsche Bank
Deutsche Bank analyst Carlo Santarelli raised his price target for Penn National Gaming (PENN) to $38 after incorporating the Pinnacle Entertainment (PNK) acquisition into his model. The analyst sees "multiple paths" to further share appreciation and keeps a Buy rating on Penn shares.
03/13/18
TLSY
03/13/18
INITIATION
TLSY
Outperform
Penn National initiated with an Outperform at Telsey Advisory
GDEN Golden Entertainment
$23.72

0.3 (1.28%)

03/13/18
TLSY
03/13/18
INITIATION
TLSY
Outperform
Golden Entertainment initiated with an Outperform at Telsey Advisory
01/18/18
JEFF
01/18/18
INITIATION
Target $38
JEFF
Buy
Golden Entertainment initiated with a Buy at Jefferies
Jefferies analyst David Katz initiated Golden Entertainment with a Buy and $38 price target.
10/25/17
MACQ
10/25/17
INITIATION
Target $34
MACQ
Outperform
Golden Entertainment initiated with an Outperform at Macquarie
Macquarie analyst Chad Beynon initiated Goldan Entertainment with an Outperform and $35 price target saying it runs a highly scalable business with heavy exposure to Southern Nevada, which is arguably the healthiest US economy. Further, the company has industry-leading exposure to millennial's spending given its Tavern concept which includes Food/Beverage and approximately 15 slot machines primarily to Vegas residents
05/15/17
RHCO
05/15/17
DOWNGRADE
RHCO
Hold
Golden Entertainment downgraded to Hold from Buy at SunTrust
SunTrust analyst Patrick Scholes downgraded Golden Entertainment to Hold and increased its price target to $16 from $15 saying shares appear fairly valued at current levels.
ERI Eldorado Resorts
$35.50

0.9 (2.60%)

02/20/18
ROTH
02/20/18
INITIATION
Target $41
ROTH
Buy
Eldorado Resorts initiated with a Buy at Roth Capital
Roth Capital analyst David Bain started Eldorado Resorts with a Buy rating and $41 price target as he sees a strong set-up for regional gaming coupled with specific, above-consensus EBITDA margin gains. Further, the analyst calculates upside optionality of over $20 per share stemming from relatively near-term, company specific, probable actions, a vast majority of which are not captured in his target price.
03/13/18
TLSY
03/13/18
INITIATION
TLSY
Outperform
Eldorado Resorts initiated with an Outperform at Telsey Advisory
04/03/18
MACQ
04/03/18
UPGRADE
MACQ
Outperform
Eldorado Resorts upgraded to Outperform from Neutral at Macquarie
04/03/18
MACQ
04/03/18
UPGRADE
Target $40
MACQ
Outperform
Eldorado Resorts upgraded to Outperform at Macquarie
As previously reported, Macquarie upgraded Eldorado Resorts to Buy from Neutral with a $40 price target, up from $39. Analyst Chad Beynon said Eldorado has a strong accretive M&A record and with Regional Gaming multiples pulling back in the quarter, and leverage back below 4x, he believes the company may be close to announcing a $1B acquisition that could add $3-$4 of equity value. Beynon also said he sees plenty of margin opportunities in the current portfolio and that Eldorado could also be a target of peers.
CHDN Churchill Downs
$235.95

-0.85 (-0.36%)

04/28/17
04/28/17
DOWNGRADE

Market Perform
Churchill Downs downgraded on limited upside at Telsey Advisory
As previously reported, Telsey Advisory downgraded Churchill Downs to Market Perform from Outperform with a $174 price target. The firm's analyst believes upside is limited at current levels and is more cautious on Big Fish division bookings for the remainder of the year.
01/18/18
JEFF
01/18/18
INITIATION
Target $261
JEFF
Hold
Churchill Downs initiated with a Hold at Jefferies
Jefferies analyst David Katz initiated Churchill Downs with a Hold rating and $261price target.
03/13/18
TLSY
03/13/18
INITIATION
TLSY
Market Perform
Churchill Downs initiated with a Market Perform at Telsey Advisory
04/28/17
TLSY
04/28/17
DOWNGRADE
TLSY
Market Perform
Churchill Downs downgraded to Market Perform from Outperform at Telsey Advisory
GLPI Gaming and Leisure Properties
$33.36

-0.44 (-1.30%)

12/19/17
UGAM
12/19/17
UPGRADE
Target $40
UGAM
Buy
Gaming and Leisure upgraded to Buy with $40 target at Union Gaming
Union Gaming analyst John DeCree upgraded Gaming and Leisure Properties (GLPI) to Buy from Hold and raised his price target for the shares to $40 from $39. The analyst sees a near-term valuation opportunity in the shares following Penn National's (PENN) acquisition of Pinnacle Entertainment (PNK). He believes Gaming and Leisure "extracted significant value from yesterday's transactions."
01/18/18
JEFF
01/18/18
INITIATION
Target $40
JEFF
Hold
Gaming and Leisure Properties initiated with a Hold at Jefferies
Jefferies analyst David Katz initiated Wynn Resorts with a Hold rating and $40 price target.
01/11/18
RHCO
01/11/18
UPGRADE
Target $41
RHCO
Buy
Gaming and Leisure Properties upgraded to Buy at SunTrust on Pinnacle deal
As reported earlier, SunTrust analyst C. Patrick Scholes upgraded Gaming and Leisure Properties (GLPI) to Buy from Hold and raised his price target to $41 from $38. The analyst says the key to the stock is the replacement of Pinnacle Entertainment (PNK) with a new deal partner BYD, adding that the market has not priced in all of the Penn National (PENN) deal accretion. Scholes also believes that Gaming and Leisure Properties should see a "robust M&A pipeline" that offers more positive catalysts.
01/11/18
RHCO
01/11/18
UPGRADE
RHCO
Buy
Gaming and Leisure Properties upgraded to Buy from Hold at SunTrust

TODAY'S FREE FLY STORIES

CTMX

CytomX Therapeutics

$15.43

-1.075 (-6.52%)

08:25
10/22/18
10/22
08:25
10/22/18
08:25
Conference/Events
CytomX Therapeutics to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CFG

Citizens Financial

$36.36

1.44 (4.12%)

08:24
10/22/18
10/22
08:24
10/22/18
08:24
Upgrade
Citizens Financial rating change  »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCI

HCI Group

$43.21

-0.35 (-0.80%)

08:23
10/22/18
10/22
08:23
10/22/18
08:23
Hot Stocks
HCI Group estimates $6M-$18M in losses from Hurricane Michael »

HCI Group has issued an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

GHDX

Genomic Health

$64.39

-3.59 (-5.28%)

08:23
10/22/18
10/22
08:23
10/22/18
08:23
Hot Stocks
Genomic Health reports results from multiple studies of Oncotype cancer tests »

Genomic Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$158.35

2.15 (1.38%)

, AKAM

Akamai

$64.27

-0.19 (-0.29%)

08:21
10/22/18
10/22
08:21
10/22/18
08:21
Conference/Events
Money 20/20 to hold a conference »

U.S.A. Money 20/20 will…

ACN

Accenture

$158.35

2.15 (1.38%)

AKAM

Akamai

$64.27

-0.19 (-0.29%)

T

AT&T

$32.86

0.36 (1.11%)

COF

Capital One

$91.67

1.32 (1.46%)

CSCO

Cisco

$45.32

-0.15 (-0.33%)

C

Citi

$68.83

0.21 (0.31%)

CTSH

Cognizant

$73.69

0.09 (0.12%)

CS

Credit Suisse

$13.14

-0.025 (-0.19%)

DBD

Diebold

$4.12

0.16 (4.04%)

DFS

Discover

$76.07

1.085 (1.45%)

GOOG

Alphabet

$1,096.41

8.51 (0.78%)

IBM

IBM

$129.16

-1.36 (-1.04%)

INFY

Infosys

$9.58

0.04 (0.42%)

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

LC

LendingClub

$3.63

0.04 (1.11%)

MA

MasterCard

$203.12

-0.69 (-0.34%)

MSFT

Microsoft

$108.55

0.01 (0.01%)

MCO

Moody's

$159.91

1.79 (1.13%)

MC

Moelis

$50.87

-0.63 (-1.22%)

V

Visa

$140.06

0.74 (0.53%)

WFC

Wells Fargo

$52.88

-0.225 (-0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 16

    Nov

  • 26

    Nov

  • 28

    Nov

  • 14

    Jan

  • 29

    Jan

  • 26

    Feb

  • 03

    Mar

  • 12

    Apr

  • 15

    Apr

  • 13

    Jul

  • 13

    Jul

  • 12

    Oct

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:21
10/22/18
10/22
08:21
10/22/18
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMED

OncoMed

$2.47

-0.17 (-6.44%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Hot Stocks
OncoMed presents interim results for navicixizumab with paclitaxel at ESMO »

OncoMed announced interim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCO

Taubman Centers

$54.20

0.29 (0.54%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Upgrade
Taubman Centers rating change  »

Taubman Centers upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 05

    Nov

  • 07

    Nov

ACN

Accenture

$158.35

2.15 (1.38%)

, ADP

ADP

$143.31

0.36 (0.25%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Conference/Events
Oracle to hold a conference »

Oracle OpenWorld…

ACN

Accenture

$158.35

2.15 (1.38%)

ADP

ADP

$143.31

0.36 (0.25%)

ATTU

Attunity

$15.81

-0.35 (-2.17%)

CTSH

Cognizant

$73.69

0.09 (0.12%)

DLR

Digital Realty

$112.62

0.86 (0.77%)

DXC

DXC Technology

$88.28

-0.08 (-0.09%)

KRO

Kronos Worldwide

$14.96

0.15 (1.01%)

INTC

Intel

$43.98

-1 (-2.22%)

IBM

IBM

$129.16

-1.36 (-1.04%)

G

Genpact

$28.76

-0.1 (-0.35%)

FEYE

FireEye

$16.98

-0.71 (-4.01%)

NTNX

Nutanix

$38.76

-2.21 (-5.39%)

PRFT

Perficient

$25.71

-0.39 (-1.49%)

SAP

SAP

$109.02

1.93 (1.80%)

TECD

Tech Data

$69.70

-1.61 (-2.26%)

TRI

Thomson Reuters

$46.61

-0.26 (-0.55%)

VMW

VMware

$140.57

-4.94 (-3.40%)

ORCL

Oracle

$47.59

0.19 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 16

    Nov

  • 06

    Dec

  • 10

    Dec

  • 03

    Mar

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$187.83

0.79 (0.42%)

08:20
10/22/18
10/22
08:20
10/22/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$70.00

-0.04 (-0.06%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

, BIIB

Biogen

$319.85

-10.4 (-3.15%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Conference/Events
CBI-Division of UBM Americas to hold a conference »

8th Annual IRT 2018 will…

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

BIIB

Biogen

$319.85

-10.4 (-3.15%)

PFE

Pfizer

$44.50

0.48 (1.09%)

AMGN

Amgen

$201.75

-1.03 (-0.51%)

VRTX

Vertex

$175.79

-3.21 (-1.79%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ADXS

Advaxis

$0.65

-0.0354 (-5.17%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

ICPT

Intercept

$95.73

-3.67 (-3.69%)

ORCL

Oracle

$47.59

0.19 (0.40%)

INCY

Incyte

$66.09

1.66 (2.58%)

SHPG

Shire

$175.16

-1.74 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 30

    Oct

  • 07

    Nov

  • 09

    Nov

  • 14

    Nov

  • 21

    Dec

  • 20

    May

XLY

Consumer Discretionary Sector SPDR

$106.34

-1.06 (-0.99%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$13.19

0.005 (0.04%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Downgrade
Barrick Gold rating change  »

Barrick Gold downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$53.13

-0.36 (-0.67%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOLD

Randgold

$81.91

0.23 (0.28%)

08:19
10/22/18
10/22
08:19
10/22/18
08:19
Downgrade
Randgold rating change  »

Randgold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$54.57

0.82 (1.53%)

08:18
10/22/18
10/22
08:18
10/22/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HALO

Halozyme

$16.37

-1.22 (-6.94%)

08:18
10/22/18
10/22
08:18
10/22/18
08:18
Hot Stocks
Halozyme reports results of data for PEGPH20 combination »

Halozyme presented data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

EGL

Engility

$31.73

0.17 (0.54%)

08:18
10/22/18
10/22
08:18
10/22/18
08:18
Hot Stocks
Engility wins $12.2M task order in Q3 »

Engility Holdings won a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

WING

Wingstop

$70.79

-0.61 (-0.85%)

08:18
10/22/18
10/22
08:18
10/22/18
08:18
Downgrade
Wingstop rating change  »

Wingstop downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

XLP

Consumer Staples Sector SPDR

$54.72

1.225 (2.29%)

08:18
10/22/18
10/22
08:18
10/22/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:18
10/22/18
10/22
08:18
10/22/18
08:18
Conference/Events
The U.S. Commodity Futures Trading Commission to hold a symposium »

26th Annual Symposium of…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.